Jury Invalidates Hologic Patents In Suit Against Rival

Law360, New York (December 18, 2009, 2:33 PM EST) -- A federal jury has handed down a victory to SenoRx Inc. in rival medical device maker Hologic Inc.'s infringement suit over two patents for a radiation delivery system used in breast cancer treatment.

Jurors in the U.S. District Court for the Northern District of California on Thursday found that SenoRx was not liable for infringement of U.S. Patent Number 6,413,204 and that both the '204 patent and U.S. Patent Number 6,482,142 were invalid, according to SenoRx.

“We are pleased with the jury's verdict,” SenoRx chairman and...
To view the full article, register now.